---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-014118"
form_type: "8-K"
ticker: "CBUS"
cik: "0001705843"
company_name: "Cibus, Inc."
filed_at: "2025-03-20T23:59:59+00:00"
generated_at: "2026-05-24T10:24:32.355999+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cibus Q4 2024 net loss $25.8M; cash $14.4M; reviews strategic alternatives

## Summary
- Q4 2024 net loss $25.8M vs $277.2M in Q4 2023 (prior-year includes $249.4M goodwill impairment); EPS -$0.87 vs -$12.59.
- Cash $14.4M at Dec 31; after Jan 2025 $21.4M net offering, expects runway into late Q3 2025.
- Board, with advisor, evaluating full range of strategic alternatives to maximize shareholder value.
- Business progress: EU Trilogue advanced; CA Rice Commission approved gene-edited Rice field trial; four Rice seed customer agreements.
- Cost-saving initiatives targeting $10M annualized run-rate, ~20% monthly cash use reduction; facility consolidation on track.

## SEC filing metadata
- accession: 0001628280-25-014118
- form_type: 8-K
- ticker: CBUS
- cik: 0001705843
- company_name: Cibus, Inc.
- filed_at: 2025-03-20T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1705843/000162828025014118/0001628280-25-014118-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1705843/000162828025014118/cbus-20250320.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-014118
- JSON: https://secwatch.observer/filing/0001628280-25-014118.json
- Plain text: https://secwatch.observer/filing/0001628280-25-014118.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.